• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

One Drop touts A1c improvements in people using mobile app on iPhone, Apple Watch

November 29, 2017 By Sarah Faulkner

One DropOne Drop today touted data from a study published in the Journal of Medical Internet Research showing that people with diabetes using the One Drop mobile app on their iPhone and Apple Watch reduce their hemoglobin A1c by 1.4%, on average.

The N.Y.-based company noted that lowering blood sugar levels can help patients lessen their risk for cardiovascular disease and microvascular complications.

“Study after study shows people using One Drop experience incredible outcomes. They eat fewer carbs, become more active, and experience dramatic results. But with the Apple Watch, results are even better,” Dr. Chandra Osborn, VP of health & behavioral informatics, said in prepared remarks.

The study included self-reported data from 256 people with diabetes who tracked at least two A1c values in the company’s diabetes management app between two and 12 months time.

“Improving A1c by 1.0% or more not only yields better quality of life for our users, but also saves them an estimated $1,324.30 per person in the first year and an estimated $8,128.83 after five years,” founder & CEO Jeff Dachi said in prepared remarks.

“We are using behavioral- and data science-backed approaches to deliver the most accessible, engaging, affordable, and clinically effective digital diabetes self-care platform in market.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, Research & Development Tagged With: onedrop

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS